dosist

dosist is a globally recognized modern wellness company founded in 2016, specializing in dose-controlled cannabis therapy products designed to help consumers naturally manage their health and well-being. The company operates in the regulated cannabis space, offering science-backed, plant-based formulations delivered through proprietary dose-controlled devices and other innovative delivery formats. dosist has built its reputation on consistency, safety, and predictability — core principles that distinguish it from conventional cannabis brands and position it firmly within the emerging health and wellness segment of the cannabis industry. The company's product portfolio includes dose-controlled vaporizer devices and cannabis gummies, with formulations targeting specific wellness outcomes. Its flagship dose pen technology delivers a precisely measured amount of cannabis per inhalation, enabling users to achieve repeatable, predictable experiences. The gummy line, marketed under a next-generation positioning, extends the brand's reach into the edibles category. dosist has received widespread recognition for its innovation, being named by Time Magazine as one of its Best Inventions, recognized by Fast Company as one of the Top 10 Most Innovative Companies in health in 2018, awarded a Big Innovation Award, and featured in GQ Magazine's Best Stuff. The brand's formulations are developed with a medical-grade ethos, utilizing rigorous third-party testing protocols and recyclable, medical-grade materials in its device construction. The company describes its products as targeted formulas, suggesting a portfolio approach where different formulations address specific wellness states or desired effects. Currently, dosist operates in California and New York, holding state-level cannabis licenses in both markets. Its California operations are conducted under CA DCC license C12-0000266-LIC through Westside Caregivers Club, Inc., while its New York operations run through Omnium Health Inc. under NY OCM license PROC-24-000047. The brand targets adult consumers 21 years of age and older seeking natural, cannabis-based alternatives for managing wellness goals. dosist positions itself at the intersection of pharmaceutical precision and consumer wellness, appealing to health-conscious adults looking for consistent, dose-controlled cannabis experiences across inhalation and edible formats.